The FDA inspects over 13,000 manufacturing sites annually to ensure drugs, devices, and food meet safety standards. Learn how inspections work, what causes failures, and how to prepare for them.
The FDA's 2025 update to biosimilar approval rules removes unnecessary clinical trials, making cheaper biologic alternatives faster and easier to bring to market. Learn how biosimilars are reviewed, why they're different from generics, and what this means for patients.